Financial Toxicity in Cancer: A Possible Solution
Topic: In recent years, more and more people have referred to the high cost of cancer care as “financial toxicity.” How did “expensive” or “costly” evolve into “toxic?” What factors contributed to the evolution? What can be done about it? Join MedPage Today and Derek Raghavan, MD, PhD, president of the Levine Cancer Institute in […]
What Next After Early End of MOSAICO HIV Vaccine Trial?
SEATTLE — The abrupt and early end of the MOSAICO HIV vaccine trial, announced last month, was the topic of a special session at the Conference on Retroviruses and Opportunistic Infections here. Results of the 3,800-participant trial were negative, with an identical 113 individuals in the vaccine regimen and placebo groups becoming infected with HIV […]
What’s Guiding Prostate Cancer Care for Gay Men?
Prostate cancer isn’t just a research topic for B. R. Simon Rosser, PhD, MPH. It’s personal. Rosser, a pioneering researcher in HIV and LGBT health at the University of Minnesota School of Public Health in Minneapolis, was diagnosed with low-risk Gleason 6 prostate cancer in 2016, at the age of 57, and went on active […]